Ascendant Diagnostics
Springdale, US · Arkansas LLC
Founders & leadership
OM
Omid MoghadamExecutive
Reported raises · per SEC filings
Form D private placements$476.9K disclosed across 1 round · 2015
▶$476.9KraisedDec 2016 · 6 investors · BiotechnologyRule 506(b)
▶$476.9KraisedDec 2016 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Omid MoghadamExecutive Officer
- Offering amount
- $5M
- Amount sold
- $476.9K
- Minimum investment
- $25K
- First sale
- Dec 2015
- Incorporated
- Limited Liability Company, Arkansas
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $175.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- How much funding has Ascendant Diagnostics raised?
- Ascendant Diagnostics has disclosed $476.9K raised across 1 round.
- Where is Ascendant Diagnostics headquartered?
- Ascendant Diagnostics is headquartered in Springdale, US.